Recent News

• 03.10.2025 - Leerink Global Healthcare Conference
• 03.06.2025 - Cartesian Therapeutics Announces New Employment Inducement Grant
• 03.03.2025 - TD Cowen 45th Annual Healthcare Conference
• 02.25.2025 - H.C. Wainwright 3rd Annual Cell Therapy Conference
• 02.18.2025 - Cartesian Therapeutics to Participate in Upcoming Investor Conferences
• 02.06.2025 - Cartesian Therapeutics Announces New Employment Inducement Grants
• 01.27.2025 - Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis
• 01.13.2025 - Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases

Recent Filings

• 03.03.2025 - EX-99.1 EX-99.1
• 03.03.2025 - 8-K Current report
• 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.27.2025 - EX-99.1 EX-99.1
• 01.27.2025 - 8-K Current report
• 01.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.15.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2025 - EFFECT Notice of Effectiveness
• 01.13.2025 - 8-K Current report